Haemapheresis Conference in the Netherlands
NL. The Hague,21.-22. November 2024

Novel Boundaries in Haemapheresis and Cell Therapy

The Hague
Link for Regisrtation: 
https://www.haemapheresisconference.nl/
REMINDER: Deadline for Abstract submission:
3. November 2024

PREVIOUS Important

CAR-T Webinar Wednesday, February 22, 2023, 3 pm to 4:30 pm (GMT+1)

The European Society for Hemapheresis is happy to host, in collaboration with
Terumo Blood and Cell technologies, an update on CAR-T with two
experts from the Hospital Clínic of Barcelona in Spain
M.Lozano Dr. Miquel Lozano Mononuclear cell collection for CAR-T therapies
,
j.Delgado

Dr. Julio Delgado Novel applications of CAR-T therapies 

 


UPDATE from the Congress Istanbul 202222nd ESFH CONGRESS   

held as a hybrid joint meeting of the
Turkish Hematology Society, WAA and ESFH
September 14th – 17th, 2022, Istanbul, Turkey

Message from the ESFH president

Abstract Award small miniAWARDS:
Abstract Award (Certificate 500€)
Dr.SerraAltuntas
Title: Is there any predictive laboratory parameter to predict the success of hemoadsorption in Sepsis  Co-Authors: Altuntas S, Yigenoglu TN, Basci S, Durmusoglu E, Silgeciler H, Kilinc A, Altuntas F., Yüksek Ihtisas University, Faculty of Medicine. Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital.
Borberg Award
Bernd Stegmayr mini
Helmut Borberg Award
Dr. Bernd Stegmayr
 Senior Prof. of UMEA University, Sweden,  Department of Public Health and Clinical Medicine
Title of the lecture: My reflections of the therapeutic power and risks of various apheresis approaches”
 

Update
PROGRAM  and
Content for downloadof the
21st  Congress    2021,  May 26th - 27th  Digital  
     Presentations  and Session Videos

H. Vrielink Convalescent Plasma: from whom and when (pdf) 
Video
Hans Vrielink  MD PhD: Convalescent plasma: from whom and when
M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic (pdf)
Video  Luca Pierell:
Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles: Vascular Aaccess: Always Central Line?  (pdf)
Video  M.J. Mustieles
:Vascular Aaccess: Always Central Line?
Video Marie Scully:
New treatment strategies in management of TTP

     Presentations  and Session Videos

H. Vrielink Convalescent Plasma: from whom and when (pdf) 
Video
Hans Vrielink  MD PhD: Convalescent plasma: from whom and when
M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic (pdf)
Video  Luca Pierell:
Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles: Vascular Aaccess: Always Central Line?  (pdf)
Video  M.J. Mustieles
:Vascular Aaccess: Always Central Line?

Webinars  produced  by  Terumo BCT  with the collaboration of ESFH
Previous 
WAA  WEBINAR September 15, 2021, 12:00 pm -2:00pm (EST)
Role of Apheresis in Cellular Therapies and Thrombosis Following COVID- 19
 https://us02web.zoom.us/webinar/register/WN_61FziquaSTGXv7uj0R1DiQ

Webinar  “How to optimize blood transfusion treatment outcomes for SCD patients?”
On-Demand Webinar One Year In: Lessons Learned About Transfusion of Convalescent Plasma (CP) for COVID-19
Presented by
Dr. Miquel Lozano, Chief, Hemotherapy Section, Hospital Clinic de Barcelona, Spain
Dr. Claudia Cohn, Chief Medical Officer, AABB
Dr. Leandro Burgos Pratx, Executive Chief of the Service of Transfusion Medicine, Hospital Italiano of Buenos Aires, Brazil
Dr. Silvano Wendel, Medical Director, Hospital Sirio Libanes São Paulo,
Brazil
Deirdre Fehily, PhD, Policy Officer – Substances of Human Origin Team, European Commission